Evidence map›Paper›PMID 39974665›Full record

ArticleMedComm2025

Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells.

Tatjana Sauerer, Franziska Bremm, Amke C Beenen, Lukas Heger, Diana Dudziak, Naomi C Bosch, Michael Erdmann, Carola Berking, Niels Schaft, Jan Dörrie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tatjana SauererDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.
Franziska BremmDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.
Amke C BeenenDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.
Lukas HegerDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.
Diana DudziakDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.
Naomi C BoschDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.
Michael ErdmannDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.
Carola BerkingDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.
Niels SchaftDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.
Jan DörrieDepartment of Dermatology Friedrich-Alexander-Universität Erlangen-Nürnberg, Uniklinikum Erlangen Comprehensive Cancer Center Erlangen - European Metropolitan Area of Nuremberg (CCC ER-EMN) and Deutsches Zentrum Immuntherapie (DZI) Erlangen Germany.ORCID https://orcid.org/0000-0002-3478-0741

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39974665
PMCPMC11835948

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.